Endo-Hepatology: Olympus^® Ultrasound Portfolio for the Management of Patients With Liver Diseases

Reprinted from December 2023 Endo-Hepatology: Olympus? Ultrasound Portfolio for the Management of Patients With Liver Diseases Introduction In the United States, liver diseases are becoming increasingly common, with nonalcoholic fatty liver disease (NAFLD) being the most prevalent.1,2 It is estimated that 100 million individu.als (30%) are affected by NAFLD,1,2 with approximately 16% of these patients advancing to nonalcoholic steatohepatitis (NASH), a severe progression of unmanaged NAFLD.1,2